A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease

NCT05662241 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

194

Enrollment

INDUSTRY

Sponsor class

Conditions

IgG4 Related Disease

Interventions

DRUG: Obexelimab
OTHER: Placebo

Sponsor

Zenas BioPharma (USA), LLC

Collaborators

[object Object]